|Year : 2016 | Volume
| Issue : 1 | Page : 28-36
Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis
Sarita Sasidharanpillai1, Aparna Govindan2, Najeeba Riyaz1, Manikoth P Binitha1, Kunnummal Muhammed1, Anza Khader1, Olasseri K Reena Mariyath1, Muhammedkutty Simin1, Kunnari Subin1
1 Department of Dermatology and Venereology, Government Medical College, Kozhikode, Kerala, India
2 Department of Pathology, Government Medical College, Kozhikode, Kerala, India
|Date of Web Publication||31-Dec-2015|
Rohini, Girish Nagar, Nallalom PO, Kozhikode - 673 027, Kerala
Source of Support: None, Conflict of Interest: None
Background: The data on the histology of cutaneous lesions of drug reaction with eosinophilia and systemic symptoms (DRESS) is limited. Aims: To study the histopathology of cutaneous lesions of drug reaction with eosinophilia and systemic symptoms (DRESS) and to identify any features with diagnostic or prognostic significance. Methods: All patients admitted to the dermatology ward of government medical college, Kozhikode from January 1, 2014 to December 31, 2014 with probable or definite DRESS as per the RegiSCAR scoring system and who were willing to undergo skin biopsy were included in this prospective study. Results: The study population comprised of nine patients. The consistent histological finding documented was the predominantly lymphocytic dermal inflammatory infiltrate. Four of the five patients whose histology revealed focal interface dermatitis and keratinocyte vacuolation with or without apoptotic keratinocytes, had elevated liver transaminases. Tissue eosinophilia was associated with disease flares. The presence of atypical lymphocytes in peripheral smear and histological evidence of dense dermal inflammatory infiltrate showed an association with hepatic involvement. Limitations: The main limitations of our study were the small sample size and our inability to carry out a detailed immunohistochemistry work-up. Conclusions: In the appropriate setting, varying combinations of epidermal hyperplasia, spongiosis, parakeratosis and individually necrotic keratinocytes in the background of lymphocyte predominant dermal infiltrate (with some atypia) favor a diagnosis of drug reaction with eosinophilia and systemic symptoms. Female sex, the presence of atypical lymphocytes in peripheral smear, dense dermal inflammatory infiltrate, tissue eosinophilia and interface dermatitis with or without keratinocyte necrosis was associated with a poor prognosis.
Keywords: Drug reaction with eosinophilia and systemic symptoms, histology, interface dermatitis
|How to cite this article:|
Sasidharanpillai S, Govindan A, Riyaz N, Binitha MP, Muhammed K, Khader A, Reena Mariyath OK, Simin M, Subin K. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis. Indian J Dermatol Venereol Leprol 2016;82:28-36
|How to cite this URL:|
Sasidharanpillai S, Govindan A, Riyaz N, Binitha MP, Muhammed K, Khader A, Reena Mariyath OK, Simin M, Subin K. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis. Indian J Dermatol Venereol Leprol [serial online] 2016 [cited 2019 Oct 15];82:28-36. Available from: http://www.ijdvl.com/text.asp?2016/82/1/28/168934
| Introduction|| |
Several years after its original description by Chaiken et al., the exact etiopathogenesis of drug reaction with eosinophilia and systemic symptoms (DRESS) or drug hypersensitivity syndrome remains unclear. Its variable clinical manifestations and the lack of reliable diagnostic criteria has made DRESS, a diagnostic challenge. Understanding the histopathological features of cutaneous lesions of DRESS in different population groups may add to the current knowledge about this drug reaction.
The most common histological feature documented in DRESS is superficial perivascular inflammatory infiltrate mainly composed of lymphocytes. Other frequently noted features include spongiosis, keratinocyte necrosis and interface dermatitis. Though peripheral blood eosinophilia is often noted in DRESS, eosinophils are only occasionally described in the dermal infiltrate. In rare instances, pseudolymphomatous histological changes have been observed. Walsh et al. associated the presence of apoptotic keratinocytes on histology with severe DRESS manifesting liver injury. Better understanding of the molecular mechanisms involved in T-cell activation and organ damage may aid in defining reliable diagnostic criteria and in improving the therapeutic options. Previous authors have indicated an important role for effector and regulatory CD8+ T-cells in precipitating the condition.
Not many studies are available on the histological aspects of DRESS, with data among the Indian population being scarcer still. In this background, we carried out a study on the histopathology of cutaneous lesions of DRESS among patients admitted in the dermatology department of our tertiary care institution during the 1-year study period.
| Methods|| |
After obtaining clearance from the institutional ethics committee, patients who were admitted to the dermatology department of Government Medical College, Kozhikode from January 1, 2014 to December 31, 2014 and who satisfied the criteria for probable adverse drug reaction on World Health Organization casualty assessment (re-challenge with the suspected drug was not carried out) were evaluated.
Each patient was carefully assessed with respect to the rash, presence or absence of facial erythema, facial and pedal edema, lymphadenopathy, mucosal and systemic involvement. Complete hemogram, renal and liver function tests and absolute eosinophil count were carried out at the time of admission. Liver function test and absolute eosinophil count, if found normal, were repeated at an interval of 5 days till the day of discharge. Peripheral smear analysis for malarial parasites and atypical cells, ultrasound examination of the abdomen and pelvis, electrocardiogram, blood culture, antinuclear antibody profile, chest radiography and serology for human immunodeficiency virus, infectious mononucleosis, leptospirosis, typhoid fever, rickettsia, dengue, chikungunya and hepatitis B, C and A infections were done wherever indicated.
Patients who satisfied the criteria for definite or probable DRESS as per the RegiSCAR scoring system developed by Kardaun et al. and who were willing to undergo a skin biopsy were included in the study after obtaining written informed consent., A preset proforma was used to collect data regarding age, sex, precipitating drug, underlying condition for which the offending drug was introduced, latent interval between drug intake and the onset of symptoms, evolution of symptoms, past medical and drug history including previous drug allergies and the investigation details.
The skin biopsy specimens were evaluated with respect to the features observed in epidermis, dermo-epidermal junction and dermis, including parakeratosis, dyskeratosis, acanthosis, spongiosis, apoptotic keratinocytes, exocytosis, focal or widespread interface dermatitis and dermal inflammation. The inflammatory cells (lymphocytes, eosinophils, neutrophils) in the epidermis and dermis were carefully studied with special reference to atypical lymphocytes. Lymphocytes with an increase in size, irregular nuclear outline and hyperchromatic nuclei were considered as atypical lymphocytes. Atypical lymphocytes having 2–3 times the size of normal lymphocytes were classified as large and others as medium sized. The localization and density of dermal infiltrate in the individual case were noted. Other dermal changes such as vasculitis and nuclear debris when present were documented. Immunohistochemistry staining for CD4 and CD8 were carried out in each case and the predominant lymphocyte in the inflammatory infiltrate was noted.
Severe DRESS was defined by the presence of one of the following: 1. hyperbilirubinemia, 2. elevation of liver transaminases (more than 10 times the normal upper limit), 3. involvement of two or more internal organs due to DRESS, 4. requirement of steroid treatment for more than 3 months, and, 4. fatal outcome due to DRESS. One mg/kg prednisolone or equivalent dexamethasone was given to those who had hyperbilirubinemia or more than 10 times elevation of liver transaminases or involvement of two or more internal organs due to DRESS. The rest received prednisolone or prednisolone equivalent at a dose of 0.5 mg/kg body weight. Steroids were tapered every 5–7 days.
Response to the withdrawal of the suspected drug, the treatment that was given and the flare ups experienced during the course of the disease were recorded. The patients were followedup till the completion of treatment.
The data were analyzed and the histopathological features were studied. An attempt was made to identify any histopathological features of diagnostic or prognostic significance.
| Results|| |
During the study period, 14, (20%) (eight men and six women out of the 70 patients who were admitted to our department with probable adverse drug reaction were diagnosed as probable or definite DRESS as per the RegiSCAR scoring system. After excluding the patient in whom the culprit was indigenous drugs and the four others who were not willing to undergo a skin biopsy, the remaining nine patients (six men and three women) were enrolled into the study. Five of them were categorized as probable and the rest as definite DRESS.
The rash was maculopapular in five patients and exfoliative dermatitis - like in the rest. All the affected patients had a rash suggestive of DRESS (facial edema and rash resolving with psoriasiform desquamation were seen in all), involving more than 50% of body surface area. The liver was the only internal organ affected in 5 of 9 patients in the study group. This was manifested as elevated liver transaminases in four patients, while one patient developed hyperbilirubinemia as well.
On most occasions, histological analysis revealed changes in both the epidermis and dermis. Focal hyperkeratosis was noted in one patient. Parakeratosis was documented in two patients, focal in one patient and confluent in the other [Figure 1]a. Spongiosis [Figure 1]b was noted in five patients. Focal exocytosis of lymphocytes was seen in four patients and in two cases it was associated with spongiosis. Acanthosis was documented in seven out of nine cases and in five cases, this was irregular [Figure 1]c. Two patients showed dyskeratosis [Figure 2]. Focal interface dermatitis with keratinocyte vacuolation and a few apoptoic keratinocytes were noted in three patients [Figure 3]. Two others showed focal interface dermatitis with keratinocyte vacuolation but without any apoptotic keratinocytes [Figure 1]b. All those whose histology revealed focal interface dermatitis, keratinocyte vacuolation and apoptotic keratinocytes and one of the two with interface dermatitis and keratinocyte vacuolation without evidence of apoptotic keratinocytes had hepatic involvement in the form of elevated transaminases. Interestingly, this finding was conspicuously absent in the patient who had the greatest derangement in the liver function test (case no: 9, [Table 1]) in the study group.
|Figure 1: (a) Biopsy from the skin lesion of a DRESS patient showing parakeratosis (H and E, ×400). (b) Biopsy from the rash of a DRESS patient showing irregular acanthosis, spongiosis and interface dermatitis (H and E, ×100). (c) Skin biopsy from a DRESS patient showing orthokeratosis, irregular acanthosis and moderate dermal perivascular inflammatory infiltrate|
Click here to view
|Figure 2: Skin biopsy from the rash of a DRESS patient showing orthokeratosis and dyskeratotic cells (arrow) (H and E, ×400)|
Click here to view
|Figure 3: Skin biopsy from the rash of one DRESS patient showing apoptotic keratinocytes (arrows) and focal interface dermatitis (H and E, ×400)|
Click here to view
Dermal edema was noted in four patients. All specimens consistently revealed a lymphocyte predominant dermal inflammatory infiltrate particularly around the blood vessels and appendages, except one patient in whom the appendages were spared. The inflammatory changes were confined to the upper dermis in six patients, whereas it involved both the upper and deep dermis in the rest. All three patients who had inflammation extending to the deep dermis had an erythrodermic rash. Three out of the five patients with internal organ involvement had a denser dermal inflammatory infiltrate (inflammatory infiltrate occupying >10% of the dermis), whereas only one of the four without systemic involvement had similar findings. On the contrary, only one of the four patients who manifested flare ups during the course of disease had an inflammatory infiltrate involving >10% of the dermis. In both patients who did not manifest hepatic involvement in spite of having a dense dermal infiltrate, the offending drug was phenytoin. Surprisingly the culprit drug was phenytoin in the lone patient who had elevated liver transaminases despite showing scanty dermal inflammatory infiltrate (<5%).
The inflammatory infiltrate was composed of lymphocytes alone in five patients. The other inflammatory cells noted in histology specimens were eosinophils (three cases), plasma cells (two cases) and neutrophils (two cases).
Though all our study subjects had peripheral blood eosinophilia, eosinophils were observed in the biopsy specimens of only three patients [Figure 4]a and [Figure 4]b. All these three had an erythrodermic rash and two of them had absolute eosinophil count above 1500 cells/mm 3. One of the patients with tissue eosinophilia had severe hepatic involvement with more than 20 times elevation of transaminases with 4–8 times elevation of bilirubin. The other two patients with tissue eosinophilia had no systemic involvement throughout the course of their disease. All three who showed eosinophilia on histology had intractable pruritus and developed flare ups on tapering steroids, necessitating a slower steroid withdrawal. Disease flares presented as intractable pruritus and reappearance of the scaly rash in the two without systemic involvement (case no 4 and 5, [Table 1]) while it manifested with reappearance of fever, pruritus and worsening of liver function status in the third (case no 9, [Table 1]). One other patient with absolute eosinophil count >1500 had no evidence of tissue eosinophilia and manifested a maculopapular skin rash (case no 6, [Table 1]).
|Figure 4: (a) Skin biopsy from the erythrodermic rash of DRESS showing perivascular inflammatory infiltrate composed mainly of lymphocytes with a few eosinophils (H and E, ×400). (b) Skin biopsy from the erythrodermic rash of DRESS showing moderately dense perivascular inflammatory infiltrate composed mainly of lymphocytes with a few atypical lymphocytes (arrows) and occasional eosinophils (arrow head) (H and E, ×400)|
Click here to view
Histology revealed the presence of atypical lymphocytes in four patients [Figure 5]. Only two (50%) of the four patients who had atypical lymphocytes in the peripheral smear had evidence of the same in skin biopsy specimen. Two of the four cases with atypical lymphocytes in skin biopsy had raised liver transaminases (case no 1 and 3, [Table 1]), whereas three of the five who lacked this histological feature had elevated liver enzymes (case no 7, 8 and 9, [Table 1]). Disease flares were documented in two of the four with atypical lymphocytes in the lesional biopsy. Disease flares manifested with reappearance of fever, rash and pruritus (case no 3, [Table 1]) in one patient (on each occasion of exacerbation, an infective etiology was ruled out by thorough evaluation), whereas the other patient who also showed tissue eosinophilia (case no 5, [Table 1]) [Figure 4]b had disease flares as already described. The fourth patient with tissue evidence of atypical lymphocytes had a relatively mild form of DRESS without any systemic complications or disease flares. Interestingly, three of the four patients whose peripheral smear analysis revealed atypical lymphocytes had hepatic involvement (case no 3, 7 and 9, [Table 1]); moreover, the two severe DRESS cases in the study population (case no 3 and 9, [Table 1]) had this finding in the peripheral smear.
|Figure 5: Skin biopsy from the maculopapular rash of a lamotrigine induced DRESS patient showing large atypical cells with irregular nuclear contour and hyperchromasia (H and E, ×1000)|
Click here to view
Immunohistochemistry revealed both CD8 [Figure 6]a and CD4 [Figure 6]b lymphocytes with CD8 predominance in all patients.
|Figure 6: (a) Immunohistochemistry revealing strong positivity for CD8 in many of the lymphocytes in the inflammatory infiltrate of a DRESS patient (immunohistochemistry, DAB chromagen ×100); (b) Immunohistochemistry of the same case revealing comparatively weaker staining for CD4 in a lesser number of lymphocytes (immunohistochemistry, DAB chromagen ×100)|
Click here to view
| Discussion|| |
Age of the study population, offending drugs, appearance of the rash noted and the hematological parameters were consistent with the existing data on DRESS.,, Although male predominance noted in this study contradicts some previous observations, no definite conclusions can be derived as the sample size is small.,
Focal hyperkeratosis, parakeratosis and dyskeratosis documented in skin lesions of DRESS were in concordance with previous data. Whether these changes are rather a feature of DRESS induced by phenytoin needs further study as in all except one with the above-mentioned features in our study, the offender was phenytoin. Whether the presence of occasional dyskeratotic cells in the lesional biopsies from phenytoin-induced DRESS with hepatic involvement has any significance needs further evaluation.
The association between hepatic involvement and histological features such as focal interface dermatitis, keratinocyte vacuolation with or without apoptotic keratinocytes observed in four of our patients was reported earlier; though in our study these histological features were absent in the patient with the greatest derangement in liver function status. Unlike the previously documented erythema multiforme lesions, the rash in all four patients with the described histology and hepatic involvement was maculopapular in nature. The patient who did not manifest the above mentioned histological features despite having high liver transaminases (case no 9, [Table 1]) and another one who had no evidence of hepatic involvement in spite of the above mentioned histological changes (case no 4, [Table 1]) had an erythrodermic rash. Whether the presence of an interface dermatitis is indicative of liver injury only in DRESS with a specific skin rash (erythema multiforme or maculopapular rash) needs further evaluation.
Further studies may tell us whether the inflammatory infiltrate extending to deep dermis is more likely to produce an erythrodermic rash as noted by us. A denser inflammatory infiltrate was associated with a higher risk for systemic involvement in the study population; but such an association was not observed for disease flares.
Our finding of the rarity of tissue eosinophilia, in spite of the common observation of peripheral blood eosinophilia in the study group was in concordance with previous reports. Tissue eosinophilia rather than eosinophilia in the peripheral blood was found to be a prognostic indicator as all three with the former had recurrent disease flares and one of them had severe DRESS.
In contrast to eosinophilia, the presence of atypical lymphocytes in the peripheral blood (rather than in tissue) was found to be a reliable prognostic indicator. A poor prognosis for patients featuring atypical lymphocytes in peripheral smear has been suggested earlier. It is not clear why eosinophilia and atypical lymphocytosis differ in this respect.
Frequent flare ups noted in all three patients with tissue eosinophilia, liver function derangement in only one of them who also happened to manifest atypical lymphocytes in peripheral smear and the documentation of hepatic involvement in the majority of those with atypical lymphocytes in peripheral smear suggest that tissue eosinophilia predicts a prolonged course with frequent exacerbations, while atypical lymphocytes in peripheral smear places a patient at greater risk for systemic involvement.
Leukocytoclastic vasculitis that has been described in occasional cases of DRESS was not documented in any of our patients. Pseudolymphomatous histology noted in one of our patients (plenty of large atypical lymphocytes) has been described earlier. Immunohistochemistry revealing a CD8 predominant T-cell infiltrate in all patients as noted by us was documented earlier.
Our finding of the relatively mild form of the disease in phenytoin induced DRESS was in concordance with literature., In our study, the lone patient who had no systemic involvement although he had atypical lymphocytes in peripheral smear, had phenytoin induced DRESS, while the other three patients with similar finding had hepatic involvement and two of them were categorized as severe DRESS. The offending drugs in the latter three were lamotrigine (two patients) and sodium valproate.
Our observation of severe DRESS in two of three women as against none among the six men with DRESS was consistent with previous data.,
The main limitations of our study were the small sample size and our inability to carry out a detailed immunohistochemistry work-up (due to financial constraints). It has recently been reported that the presence of CD8+ and granzyme B+ lymphocytes are observed in DRESS with severe cutaneous eruptions., Another limitation was the lack of information on clonality of atypical lymphocytes. Since we conducted the study among DRESS patients admitted in a tertiary referral unit the data may not represent mild forms of DRESS.
| Summary|| |
Histology of DRESS remains variable with changes involving both epidermis and dermis. We could not identify any pathognomonic histopathological feature. However, we suggest that in the appropriate setting, varying combinations of epidermal hyperplasia, spongiosis, parakeratosis and individually necrotic keratinocytes in the background of a lymphocyte predominant dermal infiltrate (with some atypia) favors a diagnosis of DRESS. The bad prognostic factors identified in the study population were female sex, dense dermal inflammation, eosinophilia in the skin biopsy specimen and atypical lymphocytes in the peripheral smear. Phenytoin induced DRESS was found to be mild, irrespective of the variables which were indicative of severe DRESS in the remaining study population. We need more prospective histological studies with a large sample size to test our observations.
We are grateful to all the faculty and postgraduates in the department for their invaluable help in conducting this study.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950;242:897-8.
Criado PR, Avancini J, Santi CG, Medrado AT, Rodrigues CE, de Carvalho JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): A complex interaction of drugs, viruses and the immune system. Isr Med Assoc J 2012;14:577-82.
Borroni G, Torti S, Pezzini C, Vassallo C, Rosso R, D'Ospina RM, et al.
Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A diagnosis that needs clinico-pathological correlation. G Ital Dermatol Venereol 2014;149:291-300.
Albrecht J, Fine LA, Piette W. Drug-associated lymphoma and pseudolymphoma: Recognition and management. Dermatol Clin 2007;25:233-44, vii.
Walsh S, Diaz-Cano S, Higgins E, Morris-Jones R, Bashir S, Bernal W, et al.
Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol 2013;168:391-401.
Shiohara T, Kano Y, Takahashi R. Current concepts on the diagnosis and pathogenesis of drug-induced hypersensitivity syndrome. Japan Med Assoc J 2009;52:347-52.
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al.
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-11.
Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Reply to: Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms. J Am Acad Dermatol 2013;69:1060-2.
Cacoub P, Musette P, Descamps V, Meyer O, Spiers C, Finzi L, et al
. The DRESS syndrome: A literature review. Am J Med 2011;124:588-97.
Sasidharanpillai S, Riyaz N, Rajan U, Binitha MP, Khader A, Mariyath OK, et al.
Drug reaction with eosinophilia and systemic symptoms: Observations from a tertiary care institution. Indian J Dermatol Venereol Leprol 2014;80:221-8.
Botelho LF, Higashi VS, Padilha MH, Enokihara MM, Porro AM. DRESS: Clinicopathological features of 10 cases from an University Hospital in São Paulo. An Bras Dermatol 2012;87:703-7.
Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: A retrospective study of 60 cases. Arch Dermatol 2010;146:1373-9.
Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al.
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. Arch Dermatol 2009;145:67-72.
Weinborn M, Barbaud A, Truchetet F, Beurey P, Germain L, Schmutz JL, et al
. An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction. Clin Transl Allergy 2014;4:P3.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]